Canon Pushes Performance of Successful varioPRINT iX-series 1-03-2023, 06:56

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection 22-10-2024, 19:00

EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future 18-03-2025, 15:00